Business ❯Healthcare ❯Pharmaceuticals

Drug Development

Clinical Trials Weight Loss Drugs GLP-1 Drugs Cancer Treatment Obesity Treatments Eli Lilly AbbVie Concussion Treatment Vaccine Rollout Pfizer Inc Oncology RELYVRIO Neuroplastogenic Therapeutics FDA Regulations Springworks Therapeutics Multiple Sclerosis Treatments Market Competition Autoimmune Disease Treatments Novartis Weight Loss Treatment Oral Weight Loss Pill Weight-Loss Drugs Tirzepatide Weight Loss Treatments COPD Treatment Obesity Drugs Biologic Medicines Investment Plans AstraZeneca Anti-Obesity Drugs Alzheimer's Disease Pfizer

AstraZeneca CEO Considers Shifting Primary Listing to U.S.

The proposal underscores CEO frustration with UK drug rules, facing board resistance, government opposition.

Samsung Biologics Announces Spin-Off of Biosimilar Unit to Form Samsung Epis Holdings

Bayer Reports 35% Profit Decline as Agricultural Weakness Persists

Eli Lilly Expands Legal Fight Against Compounded GLP-1 Drugs

Isomorphic Labs Secures $600M to Advance AI-Driven Drug Discovery

Sanofi Secures $1.9 Billion Deal for Dren Bio’s Innovative Autoimmune Therapy

Biontech Reports €700 Million Loss and Plans Workforce Restructuring

Biogen Reports Mixed Q4 Results and Lowers 2025 Outlook

SpringWorks Shares Surge on Reported Acquisition Talks with Merck KGaA

Novo Nordisk's Amycretin Shows 22% Weight Loss in Trial, Boosting Stock

AbbVie Stock Plummets After Schizophrenia Drug Trials Fail

Starboard Value Acquires $1 Billion Stake in Pfizer

Summit Therapeutics' Lung Cancer Drug Outperforms Merck's Keytruda in Trial

Biogen Raises 2024 Profit Forecast Following Strong Q2 Earnings

Roche Accelerates Development of Promising Weight-Loss Pills

Viking Therapeutics Advances Weight-Loss Drug, Shaking Up Market Leaders

Weight-Loss Drug Market Heats Up as Prices Drop and New Treatments Emerge

Novartis Raises Full-Year Guidance Following Strong Q1 Performance